The neurological manifestations of Gaucher disease type 1: the French Observatoire on Gaucher disease (FROG)
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Background: Gaucher disease (GD), the most prevalent inherited lysosomal storage disorder, is caused by deficient glucocerebrosidase activity. Type 1 GD (GD1), the most common variant, is classically considered non‐neuronopathic. Methods: We performed a national cross‐sectional observational survey—the French Observatoire on Gaucher Disease (FROG)—in patients with GD1 between March 2005 and September 2006. The study included all patients over 18 years of age with confirmed GD1 who attended participating centers for regular follow‐up. Results: One hundred and five patients were included, in whom we studied the prevalence and characteristics of relevant neurological symptoms associated with the neuraxis. Of these, 51 (49%) GD1 patients presented at least one neurological symptom. Four patients (4%) had Parkinson disease and 22 (21%) presented with at least one parkinsonian sign or at least one sign frequently associated with Parkinson disease. Five patients (5%) had a previous diagnosis of peripheral neuropathy. Other central nervous system symptoms were recorded in 20 (19%) patients and other peripheral nervous system symptoms in 39 (37%) patients. Conclusions: These data challenge the current classification of GD, and suggest that the three forms of GD each involve a different profile of neurological manifestations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations in the Glucocerebrosidase Gene and Parkinson's Disease in Ashkenazi Jews
Aharon-Peretz, J., Rosenbaum, H., & Gershoni-Baruch, R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033277 · Cited by 597 · cited 1×
“Conversely, glucocerebrosidase gene mutations have recently emerged as a potential risk factor for idiopathic PD (Aharon-Peretz et al. 2004; Bembi et al. 2003; Clark et al. 2005; Gan-Or et al. 2008; Machaczka et al. 1999; McKeran et al. 1985; Tayebi et al. 2003; Ziegler et al. 2007).”
Background
Cited by
Cerebrospinal fluid biomarkers in Parkinson disease
Parnetti, L., Castrioto, A., Chiasserini, D., Persichetti, E., Tambasco, N., El-Agnaf, O., & Calabresi, P. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.10 · Cited by 209
Glycosphingolipids and Neuroinflammation in Parkinson’s Disease
Belarbi, K., Cuvelier, E., Bonte, M.-A., Desplanque, M., Gressier, B., Devos, D., & Chartier-Harlin, M.-C. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00408-1 · Cited by 155
Patient centered guidelines for the laboratory diagnosis of Gaucher disease type 1
Dardis, A., Michelakakis, H., Rozenfeld, P., Fumic, K., Wagner, J., Pavan, E., Fuller, M., Revel-Vilk, S., Hughes, D., Cox, T., et al. (2022) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-022-02573-6 · Cited by 61
Metadata
- Authors
- Chérin, P., Rose, C., de Roux‐Serratrice, C., Tardy, D., Dobbelaere, D., Grosbois, B., Hachulla, E., Jaussaud, R., Javier, R. ‐., Noël, E., Clerson, P., & Hartmann, A.
- Venue
- Journal of Inherited Metabolic Disease
- Publisher
- Wiley
- Published
- 2010-06-02
- Volume
- 33
- Issue
- 4
- Pages
- 331-338
- ISSN
- 0141-8955 (ISSN-L)
- 1573-2665
- OpenAlex
- W2038612623
- Cited by
- 78
- References
- 1
- FWCI
- 4.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The neurological manifestations of Gaucher disease type 1: the French Observatoire on Gaucher disease (FROG). https://app.cochat.ai/papers/10.1007/s10545-010-9095-5
- The paper
- Chérin, P., Rose, C., de Roux‐Serratrice, C., Tardy, D., Dobbelaere, D., Grosbois, B., Hachulla, E., Jaussaud, R., Javier, R. ‐., Noël, E., Clerson, P., & Hartmann, A. (2010). The neurological manifestations of Gaucher disease type 1: the French Observatoire on Gaucher disease (FROG). Journal of Inherited Metabolic Disease. https://doi.org/10.1007/s10545-010-9095-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.